Your browser doesn't support javascript.
loading
Primary bone leiomyosarcoma of distal femur: case report and literature review.
Georgeanu, Vlad Alexandru; Pletosu, Raluca Ioana; Vladescu, Teodora Camelia; Bondari, Simona; Craciunescu, Andrea; Russu, Octav Marius.
Afiliação
  • Georgeanu VA; Department of Orthopedics, Carol Davila University of Medicine and Pharmacy, Department of Orthopedics and Traumatology, St. Pantelimon Emergency Clinical Hospital, Bucharest, Romania; vgeorgeanu@hotmail.com.
Rom J Morphol Embryol ; 63(3): 569-574, 2022.
Article em En | MEDLINE | ID: mdl-36588496
We present the case of a 58-year-old patient presented with a spontaneous right supracondylar fracture. The initial bone biopsy, highlighted the defining histopathological (HP) elements for a leiomyosarcoma (LMS), initially considered a metastasis. The complex imaging examinations did not reveal another tumor, so the final diagnosis was primary bone LMS. Final treatment was a wide tumor resection and reconstruction with a knee tumor prosthesis, preceded and followed by three cytostatic cycles (Doxorubicin 75 mg∕m²). The HP examination has confirmed the previous diagnosis. The key microscopic features for the diagnosis of bone LMS was: malignant mesenchymal proliferation composed of intersecting fascicles of cells with eosinophilic, fibrillary cytoplasm and pleomorphic, elongated, blunt-ended, cigar-shaped nuclei of variable sizes; variable mitotic count; presence of tumor necrosis and stroma with changes that include hyalinization, myxoid change, with absence of chondroid or osteoid matrix; diffuse positivity for smooth muscle immunohistochemical markers: smooth muscle actin, desmin, h-caldesmon. At 12 months after the tumor resection, the patient is in good condition without any sign of local recurrence or metastatic disease. LMS represents a type of soft tissue sarcoma (STS), a variant of the spindle cell sarcomas, accounting for about 7% to 10% of all STS. Bone LMS can be primary or secondary; the primary variant is very rare, representing a very small percentage (around 0.7%) of all primary malignant bone tumors, according to the literature data. Very few cases are presented in the literature; the management of this kind of tumor is controversial, especially regarding the chemo- and radiotherapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Tecidos Moles / Neoplasias Ósseas / Leiomiossarcoma Limite: Humans / Middle aged Idioma: En Revista: Rom J Morphol Embryol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Tecidos Moles / Neoplasias Ósseas / Leiomiossarcoma Limite: Humans / Middle aged Idioma: En Revista: Rom J Morphol Embryol Ano de publicação: 2022 Tipo de documento: Article